Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0N5VO
|
||||
Former ID |
DNC008381
|
||||
Drug Name |
JWH-403
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C20H32O
|
||||
Canonical SMILES |
CCCCCC(C)(C)C1=CC=C(C=C1)C2CCCC(C2)O
|
||||
InChI |
1S/C20H32O/c1-4-5-6-14-20(2,3)18-12-10-16(11-13-18)17-8-7-9-19(21)15-17/h10-13,17,19,21H,4-9,14-15H2,1-3H3/t17-,19+/m0/s1
|
||||
InChIKey |
RGRMJFXCHLLHAS-PKOBYXMFSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cannabinoid receptor 1 | Target Info | Inhibitor | [1] | |
Cannabinoid receptor 2 | Target Info | Inhibitor | [1] | ||
KEGG Pathway | Rap1 signaling pathway | ||||
Neuroactive ligand-receptor interaction | |||||
Retrograde endocannabinoid signalinghsa04080:Neuroactive ligand-receptor interaction | |||||
PANTHER Pathway | Endogenous cannabinoid signaling | ||||
Pathway Interaction Database | N-cadherin signaling events | ||||
Reactome | Class A/1 (Rhodopsin-like receptors) | ||||
G alpha (i) signalling eventsR-HSA-373076:Class A/1 (Rhodopsin-like receptors) | |||||
G alpha (i) signalling events | |||||
WikiPathways | GPCRs, Class A Rhodopsin-like | ||||
Small Ligand GPCRs | |||||
BDNF signaling pathway | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
GPCRs, OtherWP455:GPCRs, Class A Rhodopsin-like | |||||
References | |||||
REF 1 | Bioorg Med Chem. 2008 Jan 1;16(1):322-35. Epub 2007 Sep 22.Synthesis and pharmacology of 1-deoxy analogs of CP-47,497 and CP-55,940. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.